Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse

British Journal of Pharmacology

Volumn 124, Issue 3, 1998, Pages 540-546

  Rees, D D ^a,c   Monkhouse, J E ^a   Cambridge, D ^b   Moncada, S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Blood pressure; Conscious mouse; Cytokines; Endotoxin; iNOS mutant; L NMMA; Nitric oxide; Septic shock

Indexed keywords

CYTOKINE; INTERLEUKIN 6; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PATHOLOGY; PRESSOR RESPONSE; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0031747694     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701815     Document Type: Article

References (43)

1. ADERKA, D., LE, J. & VILCEK, J. (1989). IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol., 143, 3517-3523.
2. BENEDICT, C.R. & GRAHAME-SMITH, D.G. (1978). Plasma noradrenaline and adrenaline concentrations and dopamine-β-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q. J. Med., 185, 1-20.
3. BONE, R.C. (1996). The sepsis syndrome. Definition and general approach to management. Clin. Chest Med., 17, 175-181.
4. BROWN, G.C., BOLANOS, J.P., HEALES, S.J. & CLARK, J.B. (1995). Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci. Lett., 193, 201-204.
5. DAMAS, P., LEDOUX, D., NYS, M., VRINDTS, Y., DE GROOTE, D., FRANCHIMONT, P. & LAMY, M. (1992). Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg., 215, 356-362.
6. DEAKIN, A.M., PAYNE, A.N., WHITTLE, B.J.R. & MONCADA, S.M. (1995). The modulation of IL-6 and TNF-α release by nitric oxide following stimulation of J774 cells with LPS and IFN-γ. Cytokine, 7, 408-416.
7. EVANS, T., CARPENTER, A., KINDERMAN, H. & COHEN, J. (1993). Evidence of increased nitric oxide production in patients with sepsis syndrome. Circ. Shock, 41, 77-81.
8. FINK, M.P. (1996). Does tissue acidosis in sepsis indicate tissue hypoperfusion? Intensive Care Med., 22, 1144-1146.
9. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1995). Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br. J. Pharmacol., 116, 2005-2016.
10. HAYNES, W.G., NOON, J.P., WALKER, B.R. & WEBB, D.J. (1993). Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J. Hypertension, 11, 1375-1380.
11. JONES, S.B. & ROMANO, F.D. (1989). Dose- and time-dependent changes in plasma catecholamines in response to endotoxin in conscious rats. Circ. Shock, 28, 59-68.
12. JULOU-SCHAEFFER, G., GRAY, G.A., FLEMING, I., SCHOTT, C., PARRATT, J.R. & STOCLET, J.C. (1990). Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol., 259, H1038-H1043.
13. LASZLO, F., WHITTLE, B.J.R., EVANS, S.M. & MONCADA, S. (1995). Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. Eur. J. Pharmacol., 283, 47-53.
14. MACMICKING, J.D., NATHAN, C., HOM, G., CHARTRAIN, N., FLETCHER, D.S., TRUMBAUER, M., STEVENS, K., XIE, Q-W. SOKOL, K., HUTCHINSON, N., CHEN, H. & MUDGETT, J.S. (1995). Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell, 81, 641-650.
15. MEYER, J., TRABER, L.D., NELSON, S., LENTZ, C.W., NAKAZAWA, H., HERNDON, D.N., NODA, H. & TRABER, D.L. (1992). Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J. Appl. Physiol., 73, 324-328.
16. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
17. G-monomethyl-L-arginine. J. Cardiovasc. Pharmacol., 20, S132-S134.
18. OCHOA, J.B., UDEKWU, A.O., BILLIAR, T.R., CURRAN, R.D., CERRA, F.B., SIMMONS, R.L. & PEITZMAN, A.B. (1991). Nitric oxide levels in patients following trauma and during sepsis. Ann. Surg., 214, 621-626.
19. PARRILLO, J.E. (1993). Pathogenetic mechanisms of septic shock. N. Engl. J. Med., 328, 1471-1477.
20. G-mono-,di- and trimethylated arginines. Acta Biochim. Biophys. Acad. Sci. Hung., 12, 191-196.
21. PETROS, A., BENNETT, D. & VALLANCE, P. (1991). Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet, 338, 1557-1558.
22. PETROS, A., LAMB, G., LEONE, A., MONCADA, S., BENNETT, D. & VALLANCE, P. (1994). Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res., 28, 34-39.
23. RADOMSKI, M.W. (1995). Nitric oxide: Biologic mediator, modulator and effector. Annals. Med., 27, 321-329.
24. REES, D.D. (1995). Role of nitric oxide in the vascular dysfunction of septic shock. Biochem. Soc. Trans., 23, 1025-1029.
25. REES, D.D., CELLEK, S., PALMER, R.M.J. & MONCADA, S. (1990a). Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock. Biochem. Biophys. Res. Commun., 173, 541-547.
26. REES, D.D., CUNHA, F.Q., ASSREUY, J., HERMAN, A. & MONCADA, S. (1995). Sequential induction of nitric oxide synthase by Corynebacterium parvum in different organs of the mouse. Br. J. Pharmacol., 114, 689-693.
27. REES, D.D., PALMER, R.M.J. & MONCADA, S. (1989). Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A., 86, 3375-3378.
28. REES, D.D., PALMER, R.M.J., SCHULZ, R., HODSON, H.F. & MONCADA, S. (1990b). Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101, 746-752.
29. ROOT, R.K. & JACOBS, R. (1991). Septicaemia and septic shock. In Harrison's Principles of Internal Medicine, ed. Wilson, J.D., Braunwald, E., Isselbacher, K.J., Petersdorf, R.G., Martin, J.B., Fauci, A.S. & Root, R.K. pp. 502-507. 12th ed. New York: McGraw-Hill.
30. ROSSAINT, R., FALKE, K.J., SLAMA, K., PISON, U. & ZAPOL, W.M. (1993). Inhaled nitric oxide for the adult respiratory distress syndrome. N. Eng. J. Med., 328, 399-405.
31. ++-independent nitric oxide synthases. FEBS LETT. 291, 145-149.
32. SCANNELL, J.P., AX, H.A., PRUESS, D.L., WILLIAMS, T., DEMNY, T.C. & STEMPEL, A. (1972). Antimetabolites produced by microorganisms. VI, L-N-(1-iminoethyl) ornithine. J. Antibiot., 25, 179-184.
33. SCHLAG, G., REDL, H., DAVIES, J. & HALLER, I. (1994). Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock, 2, 10-18.
34. SHEEHAN, K.C.F., RUDDLE, N.H. & SCHREIBER, R.D. (1989). Generation and characterization of hamster monoclonal antibodies that neutralize murine tumour necrosis factors. J. Immunol., 142, 3884-3893.
35. SILVA, A.T., BAYSTON, K.F. & COHEN, J. (1990). Prophylactic and therapeutic effects of a monoclonal antibody to tumour necrosis factor-α in experimental gram-negative shock. J. Infect. Dis., 162, 421-427.
36. SUFFREDINI, A.F., FROMM, R.E., PARKER, M.M., BRENNER, M., KOVACS, J.A. & WESLEY, R.A. (1989). The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med., 321, 280-287.
37. TAVEIRA DA SILVA, A.M., KAULBACH, H.C., CHUIDIAN, F.S., LAMBERT, D.R., SUFFREDINI, A.F. & DANNER, R.L. (1993). Shock and multiple organ dysfunction after self administration of salmonella endotoxin. N. Engl. J. Med., 328, 1457-1460.
38. THIEMERMANN, C. (1994). The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv. Pharmacol., 28, 45-79.
39. THIEMERMANN, C. & VANE, J.R. (1990). Inhibition of nitric oxide synthesis reduces the hypotension induced bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol., 182, 591-595.
40. VALLANCE, P. & MONCADA, S. (1993). Role of endogenous nitric oxide in septic shock. New Horiz., 1, 77-86.
41. WHITTLE, B.J.R. (1995). Nitric oxide in physiology and pathology. Histochem. J., 27, 727-737.
42. WRIGHT, C.E., REES, D.D. & MONCADA, S. (1992). Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res., 26, 48-57.
43. WEI, X-Q., CHARLES, I.G., SMITH, A., URE, J., FENG, G-J., HUANG, F-P., XU, D., MULLER, W., MONCADA, S. & LIEW, F.Y. (1995). Altered immune responses in mice lacking inducible nitric oxide synthase. Nature, 375, 408-411.